FDA Approves First At-Home Starting Dose for Leqembi Alzheimer’s Treatment RBC keeps Outperform at $242, Truist upgrades to Buy ($235 target). Credit: Hannah Yoon/The Washington Post/Getty Images Subscribe now Already have an account? Sign in.
